WuXi Biologics (Cayman) Inc. (WXXWY)

91.93% (1Y)

Market Cap	14.12B
Revenue (ttm)	2.56B
Net Income (ttm)	459.79M
Shares Out	n/a
EPS (ttm)	0.11
PE Ratio	30.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,904
Average Volume	48,328
Open	6.84
Previous Close	7.12
Day's Range	6.65 - 6.90
52-Week Range	2.58 - 7.30
Beta	0.73
RSI	55.32
Earnings Date	Mar 21, 2025

About WuXi Biologics

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufact...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2014
• Employees: 12,740
• Stock Exchange: OTCMKTS
• Ticker Symbol: WXXWY

Financial Performance

In 2024, WuXi Biologics's revenue was 18.68 billion, an increase of 9.63% compared to the previous year's 17.03 billion. Earnings were 3.36 billion, a decrease of -1.28%.

Financial numbers in CNY